Kristen H. Lee, M.D.
Assistant Professor, Division of Rheumatology, Department of Medicine
To see if Kristen H. Lee is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Specialties
Rheumatology
Rheumatology, Allergy and Clinical Immunology
Department
Locations and Contact
Additional Numbers
Physician Referrals
Philosophy of Care
Rheumatologic conditions are systemic diseases and can manifest in different body systems including joints, eyes, skin, lungs, and kidneys which makes the diagnosis and treatment challenging. My approach to a patient with a rheumatologic symptom or disease is a holistic and comprehensive one, beginning with a detailed history and exam that takes into consideration the psychosocial factors and the impact on overall quality of life.
Clinical Interests
Dr. Kristen Lee is a rheumatologist offering care for adults with various autoimmune and rheumatologic conditions including rheumatoid arthritis, lupus, gout, psoriatic arthritis, ankylosing spondylitis, vasculitis, myositis, sjogren's, scleroderma, and osteoporosis.
Research/Academic Interests
Dr. Lee's research is in the therapeutic area for inflammatory arthritis. She is concurrently a Senior Medical Director in Medical Affairs at Pfizer where she is the Rheumatology Team Lead supporting Xeljanz. She is also a fellow of the American College of Rheumatology (ACR).
Dr. Lee’s interests include the pathogenesis of inflammatory arthritis and novel therapies for the treatment of autoimmune diseases. She is committed to the education of patients, fellows, and the rheumatology community. She recently relocated from New York City to the Bay Area in California.
Division
Rheumatology, Allergy and Clinical Immunology
Medical School
M.D., SUNY Stony Brook University School of Medicine, Stony Brook NY 2007
Internship
Internal Medicine, NYU School of Medicine/NYU Langone Hospital, New York NY 2007-2008
Residency
Internal Medicine, NYU School of Medicine/NYU Langone Hospital, New York NY 2008-2010
Fellowship
Rheumatology, NYU School of Medicine/NYU Langone Hospital, New York NY 2010-2012
Fleischmann R, Haraoui B, Buch MH, Gold D, Sawyerr G, Shi H, Diehl A, Lee K. Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate. Rheumatol Ther. 2022 Dec 19. doi:10.1007/s40744-022-00511-3. Epub ahead of print. PMID:36534208.
Charles-Schoeman C, Fleischmann R, Mysler E, Greenwald M, Wang C, Chen A-S, Connell CA, Woolcott J, Menon S, Chen Y, Lee K, Szekanecz Z. The risk of venous thromboembolic events in patients with RA aged ≥ 50 years with ≥1 cardiovascular risk factor: results from a Phase 3b/4 randomized safety study of tofacitinib vs TNF inhibitors [abstract]. Arthritis Rheumatol. 2021;73(suppl 9).
Steuer AB, Bieber AK, Lee K, Meehan SA, Lo Sicco K. Paradoxical Mucositis Associated With Anti-Tumor Necrosis Factor Therapy. J Clin Rheumatol. 2020 Dec;26(8):e309-e310. doi:10.1097/RHU.0000000000001163. PMID:31524852.
Berk-Krauss J, Lee K, Lo Sicco KI, Liebman TN. Eczematous reaction to IVIG for the treatment of dermatomyositis. Int J Womens Dermatol. 2018 Jun 23;4(3):170-173. doi:10.1016/j.ijwd.2018.03.004. PMID:30175220.
Yang A, Bomfim F, Lee K, Attur M, Abramson SB, Samuels J. Diagnostic and Prognostic Value of Ultrasound Compared with Plain Radiographs in Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2018;70 (suppl 9).
Modjinou DV, Krasnokutsky S, Gyftopoulos S, Pike VC, Karis E, Keenan RT, Lee K, Crittenden DB, Samuels J, Pillinger MH. Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking. Clin Rheumatol. 2017 Sep;36(9):2101-2107. doi:10.1007/s10067-017-3729-z. Epub 2017 Jun 16. PMID:28623421.
Reed JH, Jain M, Lee K, Kandimalla ER, Faridi MH, Buyon JP, Gupta V, Clancy RM. Complement receptor 3 influences toll-like receptor 7/8-dependent inflammation: implications for autoimmune diseases characterized by antibody reactivity to ribonucleoproteins. J Biol Chem. 2013 Mar 29;288(13):9077-83. doi:10.1074/jbc.M112.403303. Epub 2013 Feb 5. PMID:23386618.
Reed JH, Clancy RM, Lee KH, Saxena A, Izmirly PM, Buyon JP. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus. Arthritis Care Res (Hoboken). 2012 Sep;64(9):1373-81. doi:10.1002/acr.21704. PMID:22511615.
Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, Krasnokutsky S, Oh C, Pillinger MH. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med. 2011 Feb;124(2):155-63. doi:10.1016/j.amjmed.2010.09.012. PMID:21295195.